Sales & Marketing The rise of NP/PA influence: Why and how pharma marketing st... The rise of NP/PA influence is not a passing trend; it is a structural realignment of US healthcare. These clinicians are the connective tissue.
Sales & Marketing Sponsored The AI imperative: Establishing the standard for modern clin... The findings from the Medidata-commissioned survey confirm that AI implementation in clinical trials has moved firmly beyond theoretical discussion.
Sales & Marketing Omnichannel didn’t fail biopharma. Our metrics did. Omnichannel didn’t fail pharma. Our metrics did. In 2026, fixing that won’t be optional.
Sales & Marketing Sponsored Bridging science and strategy: Medical Affairs at the heart ... In this sponsored podcast, Cheryl Lubbert and Carolyn Whiting of Reverba discuss a new approach to pharma marketing, omnichannel, and medical affairs.
Sales & Marketing Sponsored 12 Questions with Jim Sage Jim Sage is a seasoned global pharmaceutical executive with extensive marketing, commercial, and leadership experience across major therapeutic areas.
Sales & Marketing Unlocking pharma launch potential: Integrated data strategie... Launch teams need real-time, integrated intelligence to navigate tighter markets, faster timelines, and rising expectations.
Oncology ASCO 2026: All about DNA damage response, with Luke Piggot Luke Piggot, a principal scientist at Debiopharm, shares some recent data and news about the company's work in DNA damage repair inhibitors.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.